ARCHIVES

The President’s Cancer Panel publishes its annual report

This article is from The Cancer Letter archive.

Vol. 37 No. 18 | May 6, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Proposes Inviting Academic Labs To Submit New Therapies For Development

January 16, 1998

Volasertib and LDAC Doubled Response in Older Patients

July 25, 2014

SWOG Five Drug Adjuvant Breast Study Shows Remarkable Survival For Older, Younger Women

March 30, 1979

Celgene Begins Two Studies With Hoffmann-La Roche.

June 29, 2001

UCSF AIDS, Cancer Specimen Resource Bank Funded, Renamed

November 15, 2002

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001